Xuemeng Guo

784 total citations · 1 hit paper
28 papers, 584 citations indexed

About

Xuemeng Guo is a scholar working on Immunology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Xuemeng Guo has authored 28 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 10 papers in Molecular Biology and 7 papers in Biomedical Engineering. Recurrent topics in Xuemeng Guo's work include Immunotherapy and Immune Responses (11 papers), Nanoplatforms for cancer theranostics (7 papers) and RNA Interference and Gene Delivery (5 papers). Xuemeng Guo is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Nanoplatforms for cancer theranostics (7 papers) and RNA Interference and Gene Delivery (5 papers). Xuemeng Guo collaborates with scholars based in China. Xuemeng Guo's co-authors include Jian You, Lihua Luo, Junlei Zhang, Zhenyu Luo, Mengshi Jiang, Yingying Shi, Bing Qin, Jiaxin Huang, Yichao Lu and Yongzhong Du and has published in prestigious journals such as Nature Communications, ACS Nano and Nature Nanotechnology.

In The Last Decade

Xuemeng Guo

25 papers receiving 579 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutrophil hitchhiking for drug delivery to the bone marrow

2023 118 citations Zhenyu Luo, Yichao Lu et al. Nature Nanotechnology profile →

Peers

Countries citing papers authored by Xuemeng Guo

Since Specialization

Citations

This map shows the geographic impact of Xuemeng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuemeng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuemeng Guo more than expected).

Fields of papers citing papers by Xuemeng Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuemeng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuemeng Guo. The network helps show where Xuemeng Guo may publish in the future.

Co-authorship network of co-authors of Xuemeng Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xuemeng Guo. A scholar is included among the top collaborators of Xuemeng Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuemeng Guo. Xuemeng Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sustained Activation of Nrf2 Antioxidant Pathway by Flexible Liposome Based on Low Phase Transition Temperature to Delay Skin Aging 2025 ·Advanced Healthcare Materials ·(unknown), Yilong Hu, Wanting Ji, Sijie Wang, Ying Zhu, Qing Lin, Xiaoqi Zhao, Huan‐Li Zhou, Xuemeng Guo, Ying Liu, Yingying Shi, Junlei Zhang, Zhenyu Luo, Jiaxin Huang, Hang Yin, Lihua Luo, Jian You	0
2	Inhibition of PDT-induced PGE2 surge for enhanced photo-immunotherapy 2025 ·Biomaterials ·Xu Liu, Jiaxin Huang, Huan‐Li Zhou, Sijie Wang, Xuemeng Guo, (unknown), Xiang Li, Yichao Lu, Yongzhong Du, Fuchun Yang, Lihua Luo, Jian You	4
3	Transporting via Neutrophil as a Key Mechanism for Nanoparticle Redistribution to Tumor and Spleen 2025 ·ACS Nano ·Sijie Wang, (unknown), (unknown), Xiaoqi Zhao, Y.X. Zhang, Xuemeng Guo, Huan‐Li Zhou, Ying Zhu, (unknown), (unknown), Zhenyu Luo, (unknown), Junlei Zhang, Jian Liu, Junchao Qian, Lihua Luo, Jian You	0
4	Reductive Adjuvant Nanosystem for Alleviated Atopic Dermatitis Syndromes 2025 ·ACS Nano ·Yichao Lu, Xinyu Shan, (unknown), Huan‐Li Zhou, Ying Zhu, Sijie Wang, Zhenyu Luo, (unknown), Xuemeng Guo, Yingying Shi, Yilong Hu, Huihui Liu, Junlei Zhang, Ping Huang, Lihua Luo, Jian You	0
5	Optimizing Adoptive Cell Therapy for Solid Tumors via Epigenetic Regulation of T‐cell Destiny 2024 ·Advanced Healthcare Materials ·Xuemeng Guo, Xiang Li, Sijie Wang, Yingying Shi, (unknown), Xu Liu, Yichao Lu, Junlei Zhang, Lihua Luo, Jian You	2
6	Remodeling the hepatic immune microenvironment and demolishing T cell traps to enhance immunotherapy efficacy in liver metastasis 2024 ·Journal of Controlled Release ·Zhenyu Luo, Mengshi Jiang, (unknown), Xiaoqi Zhao, Huihui Liu, Sijie Wang, Qing Lin, (unknown), Xuemeng Guo, Xu Liu, Xinyu Shan, Yichao Lu, Yingying Shi, Lihua Luo, (unknown)	3
7	Chronological Management of Adjuvant Effect for Optimized mRNA Vaccine Inspired by Natural Virus Infection 2024 ·ACS Nano ·(unknown), Yingying Shi, Xuemeng Guo, (unknown), (unknown), Yilong Hu, Xü Liu, Jiang Zhu, Rong Kuang, Jian You	1
8	The effect of blood velocity in solid tumor on intratumorally accumulation and penetration of nanocarriers and drugs 2023 ·Nano Today ·Sijie Wang, Junlei Zhang, Huihui Liu, Xuemeng Guo, Yichao Lu, Guannan Guan, Zhenyu Luo, Yingying Shi, Mengshi Jiang, (unknown), Huan‐Li Zhou, Xiaoqi Zhao, Lihua Luo, Jian You	4
9	Antioxidant nanoemulsion loaded with latanoprost enables highly effective glaucoma treatment 2023 ·Journal of Controlled Release ·Xuemeng Guo, Junlei Zhang, (unknown), Yichao Lu, Yingying Shi, Xiang Li, (unknown), Jiaxin Huang, Huihui Liu, Huan‐Li Zhou, Qingpo Li, Lihua Luo, Jian You	14
10	Enhancing tumor immunotherapy via photodynamic therapy with a cascade reaction of reactive oxygen species and sustaining nutrient supply 2023 ·Journal of Controlled Release ·Xu Liu, Junlei Zhang, Xuemeng Guo, Jiaxin Huang, (unknown), Xiaoqi Zhao, (unknown), Xiang Li, Jian You, Lihua Luo	10
11	Neutrophil hitchhiking for drug delivery to the bone marrow breakdown → 2023 ·Nature Nanotechnology ·Zhenyu Luo, Yichao Lu, Yingying Shi, Mengshi Jiang, Xinyu Shan, Xiang Li, Junlei Zhang, Bing Qin, Xü Liu, Xuemeng Guo, Jiaxin Huang, Yu Liu, Sijie Wang, Qingpo Li, Lihua Luo, Jian You	118
12	Precisely Regulating M2 Subtype Macrophages for Renal Fibrosis Resolution 2023 ·ACS Nano ·Lihua Luo, Sijie Wang, Yilong Hu, Litong Wang, Xin‐Dong Jiang, Junlei Zhang, Xü Liu, Xuemeng Guo, Zhenyu Luo, Chunqi Zhu, (unknown), Yeqing Li, Jian You, Fuchun Yang	52
13	Reductive lipid nanoparticles loaded with vinorelbine inhibit chemotherapy-induced invasion of cancer cells by modulating ENPP2 2023 ·Nano Research ·Xiaoqi Zhao, Xuemeng Guo, (unknown), (unknown), Zhenyu Luo, (unknown), Yichao Lu, Hang Yin, Sijie Wang, Huihui Liu, Junlei Zhang, Lihua Luo, Jian You	4
14	Structural and biochemical characteristics of mRNA nanoparticles determine anti–SARS-CoV-2 humoral and cellular immune responses 2022 ·Science Advances ·Yingying Shi, Jiaxin Huang, Yu Liu, (unknown), Xuemeng Guo, Jianhua Li, Liming Gong, Xin Zhou, (unknown), Yunqing Qiu, Jian You, Yan Lou	26
15	Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapy 2022 ·Theranostics ·Yingying Shi, Yu Liu, Jiaxin Huang, Zhenyu Luo, Xuemeng Guo, Mengshi Jiang, (unknown), Yichao Lu, Xu Liu, Xinyu Shan, Lihua Luo, Jian You	17
16	Recruiting T cells and sensitizing tumors to NKG2D immune surveillance for robust antitumor immune response 2022 ·Journal of Controlled Release ·Xiang Li, Xuemeng Guo, Jiaxin Huang, Qing Lin, Bing Qin, Mengshi Jiang, Xinyu Shan, Zhenyu Luo, Junlei Zhang, Yingying Shi, Yichao Lu, Xu Liu, Yongzhong Du, Fuchun Yang, Lihua Luo, (unknown)	6
17	A therapeutic DC vaccine with maintained immunological activity exhibits robust anti-tumor efficacy 2022 ·Journal of Controlled Release ·Yichao Lu, Yingying Shi, Yu Liu, Zhenyu Luo, Junlei Zhang, Mengshi Jiang, (unknown), Xu Liu, Xuemeng Guo, Bing Qin, Hang Yin, Yongzhong Du, (unknown), (unknown), Guannan Guan, Lihua Luo, Jian You	15
18	Preventing acute lung injury from progressing to pulmonary fibrosis by maintaining ERS homeostasis through a multistage targeting nanomicelle 2022 ·Nano Today ·Lihua Luo, Zhenyu Luo, Junlei Zhang, Xü Liu, Jiaxin Huang, Sijie Wang, (unknown), Xuemeng Guo, Yilong Hu, Yichao Lu, Xinyu Shan, Huihui Liu, Yingying Shi, Yongzhong Du, Fuchun Yang, Jian You	15
19	Cocktail strategy for ‘cold’ tumors therapy via active recruitment of CD8+ T cells and enhancing their function 2021 ·Journal of Controlled Release ·Xiang Li, Lihua Luo, Mengshi Jiang, Chunqi Zhu, Yingying Shi, Junlei Zhang, Bing Qin, Zhenyu Luo, Xuemeng Guo, Yichao Lu, Xinyu Shan, (unknown), Yongzhong Du, Ling Peng, Jian You	27
20	Regulating immune memory and reversing tumor thermotolerance through a step-by-step starving-photothermal therapy 2021 ·Journal of Nanobiotechnology ·Lihua Luo, Bing Qin, Mengshi Jiang, Lin Xie, Zhenyu Luo, Xuemeng Guo, Junlei Zhang, Xiang Li, Chunqi Zhu, Yongzhong Du, Ling Peng, Jian You	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact